✦ LIBER ✦

A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) Trial

✍ Scribed by Gilles Montalescot; Georges Sideris; Catherine Meuleman; Claire Bal-dit-Sollier; Nicolas Lellouche; Ph. Gabriel Steg; Michel Slama; Olivier Milleron; Jean-Philippe Collet; Patrick Henry; Farzin Beygui; Ludovic Drouet

Book ID: 119266087
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 596 KB
Volume: 48
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2006.04.090

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of a 600-mg Loading Dose of Clop

Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting

✍ Thomas Cuisset; Corinne Frere; Jacques Quilici; Pierre-Emmanuel Morange; Lyassin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Randomized trial comparing 600- with 300

Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non–ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial

✍ Gerald Yong; Jamie Rankin; Louise Ferguson; Jim Thom; John French; David Brieger 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Role of the T744C polymorphism of the P2

Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome

✍ Thomas Cuisset; Corinne Frere; Jacques Quilici; Pierre-Emmanuel Morange; Noémie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Study design and rationale of a comparis

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial

✍ Chee Tang Chin; Matthew T. Roe; Keith A.A. Fox; Dorairaj Prabhakaran; Debra A. M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 311 KB